Ned Bartlett

25PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNanomedicinePredictive and prognostic markersBiostatistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 20, 2026
Neoadjuvant Immune Therapy in Patients With Melanoma: Response and Toxicity in a Non-Clinical Trial Setting.

|Jun 04, 2026
Neoadjuvant PD-1 Blockade in Surgically Resectable Desmoplastic Melanoma: Cohort A of the Phase 2 SWOG S1512 Trial.

|May 08, 2026
Perspective Editorial: Assessment of Survival Benefit from Sentinel Node Biopsy for Melanoma: A Systematic Review and Meta-analysis.

|Nov 25, 2025
Outcomes of Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma.

Edmund K Bartlett, Hannah L Kalvin, Christopher A Barker

|Sep 24, 2025
Histologic Subvariants of Retroperitoneal Well-Differentiated Liposarcoma Show Evidence of Clinical and Genomic Progression Toward Dedifferentiated Liposarcoma.

George Z Li, Jay Lee, Karissa Whiting

|Jul 22, 2025
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.

Ciara M Kelly, Martina Bradic, Sara Saunds

Pageof 5

Frequent Collaborators

4 joint publications

Li-Xuan Qin

4 joint publications

Evan Rosenbaum

3 joint publications

Jason E Chan

3 joint publications

Cristina R Antonescu